651 related articles for article (PubMed ID: 24445538)
1. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
Wiesner T; He J; Yelensky R; Esteve-Puig R; Botton T; Yeh I; Lipson D; Otto G; Brennan K; Murali R; Garrido M; Miller VA; Ross JS; Berger MF; Sparatta A; Palmedo G; Cerroni L; Busam KJ; Kutzner H; Cronin MT; Stephens PJ; Bastian BC
Nat Commun; 2014; 5():3116. PubMed ID: 24445538
[TBL] [Abstract][Full Text] [Related]
2. Spitz melanoma is a distinct subset of spitzoid melanoma.
Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
[TBL] [Abstract][Full Text] [Related]
3. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of spitzoid tumours: A clinical study.
Hafiji J; Rytina E; Burrows NP
Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697
[TBL] [Abstract][Full Text] [Related]
5. The role of gene fusions in melanocytic neoplasms.
Quan VL; Panah E; Zhang B; Shi K; Mohan LS; Gerami P
J Cutan Pathol; 2019 Nov; 46(11):878-887. PubMed ID: 31152596
[TBL] [Abstract][Full Text] [Related]
6. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
[TBL] [Abstract][Full Text] [Related]
7. [Morphological and genetic aspects of Spitz tumors].
Wiesner T; Kutzner H
Pathologe; 2015 Feb; 36(1):37-43, 45. PubMed ID: 25613920
[TBL] [Abstract][Full Text] [Related]
8. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
[TBL] [Abstract][Full Text] [Related]
9. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
[TBL] [Abstract][Full Text] [Related]
10. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
11. Spitz melanocytic tumours - a review.
Yeh I; Busam KJ
Histopathology; 2022 Jan; 80(1):122-134. PubMed ID: 34958498
[TBL] [Abstract][Full Text] [Related]
12. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.
Tetzlaff MT; Reuben A; Billings SD; Prieto VG; Curry JL
Clin Lab Med; 2017 Sep; 37(3):431-448. PubMed ID: 28802494
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
15. Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society.
Lallas A; Apalla Z; Ioannides D; Lazaridou E; Kyrgidis A; Broganelli P; Alfano R; Zalaudek I; Argenziano G;
Br J Dermatol; 2017 Sep; 177(3):645-655. PubMed ID: 28118479
[TBL] [Abstract][Full Text] [Related]
16. NTRK3 kinase fusions in Spitz tumours.
Yeh I; Tee MK; Botton T; Shain AH; Sparatta AJ; Gagnon A; Vemula SS; Garrido MC; Nakamaru K; Isoyama T; McCalmont TH; LeBoit PE; Bastian BC
J Pathol; 2016 Nov; 240(3):282-290. PubMed ID: 27477320
[TBL] [Abstract][Full Text] [Related]
17. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
18. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract][Full Text] [Related]
19. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
[TBL] [Abstract][Full Text] [Related]
20. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]